Singular Genomics Systems
1 known investors
Singular Genomics develops spatial pathology technology to map molecules and cells directly in tissue for disease characterization. The company serves researchers and pathologists in biomedical research and diagnostics.
BiotechDeep TechMedical Devices
Founders & leadership
JS
John StarkCEO
AB
Aaron BerlinCTO